Company news

Imugene Ltd news in 2021

Imugene Ltd's news releases, calls and decks from 2021, newest first.

View company

FDA ind approval for the phase 2 clinical trial of her-vaxx

December 12, 2021

Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc

December 6, 2021

S&P DJI Announces December 2021 Quarterly Rebalance

December 3, 2021

Clinical Trial Supply Agreement with Merck KGaA and Pfizer

November 15, 2021

Investor Presentation Imugene Eureka Therapeutics

October 31, 2021

First patient dosed in phase i clinical trial of checkvacc

October 20, 2021

Imugene HER-Vaxx Immunotherapy Patent Granted in Japan

September 21, 2021

S&P DJI Announces September 2021 Quarterly Rebalance

September 3, 2021

Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials

August 31, 2021

Appendix 4E and Full Year Statutory Accounts

August 30, 2021

Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx

August 26, 2021

Response to ASX Query

August 23, 2021

Research partnership with Celularity for solid tumors

August 4, 2021

Prospectus for SPP and Placement Options Offer

July 29, 2021

Imugene completes $90 M placement and launches $5 M SPP

July 28, 2021

Appendix 4C - Quarterly Report

July 23, 2021

FDA ind approval of new oncolytic virotherapy checkvacc

July 1, 2021

Investor Presentation

May 17, 2021

Prestigious Research Journal Publish HER-Vaxx Phase 1B Data

April 29, 2021

Appendix 4C - quarterly

April 23, 2021

Imugene announces clinical milestone for HER-Vaxx

April 20, 2021

Imugene Oncolytic Virus Presentation at AACR 2021 Meeting

April 11, 2021

Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX

April 6, 2021

S&P DJI Announces March 2021 Quarterly Rebalance

March 12, 2021

Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting

March 10, 2021

Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial

February 11, 2021

Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial

January 20, 2021

Imugene completes recruitment to her-vaxx phase 2 trialim

January 6, 2021

Decks in 2021